In summary, ENO1 is overexpressed in NSCLC, promoting cell glycolysis, proliferation, migration, invasion, and tumorigenesis by activating the FAK-mediated PI3K/AKT pathway and further modulating their downstream signal molecules. Here, AKT1 is linked to non-small cell lung carcinoma.